News

Nurse Practitioner – Full or Part Time Residential Eldercare Services   🌟 Join Our Exceptional Team as a Nurse Practitioner! 🌟 Are you passionate about providing the highest standard of care to the elderly? Do you thrive in a collaborative and supportive work environment? We have an exciting job opportunity for Nurse Practitioners to join our unique totally mobile general practice dedicated to eldercare. At Residential Eldercare Services, we believe in fostering a dynamic and fulfilling...

Te Whata Kura is the new national antimicrobial guideline. It includes revised guidance around: Cellulitis, irrespective of patient BMI, 1000mg Flucloxacillin QID with food for 5 days. Cystitis, uncomplicated: Nitrofurantoin (Micronised version trade name Macrobid), so as not to confuse with the regular Nitrofurantoin and underdose the patient (100 mg BD for 5 days with food). Adult unilateral otitis media and no severe symptoms no antibiotics needed. Adult bilateral otitis media: Amoxicillin...

Kia ora, Pharmac is proposing to fund ferric derisomaltose (Monofer) in hospitals for people with low iron levels who have experienced low phosphate levels (hypophosphataemia) after other iron infusions.More information about the consultation, including how to provide feedback, is available here   Proposal to fund ferric derisomaltose (Monofer) in hospitals for people who have experienced hypophosphataemia after other iron infusions Public consultation on the proposal will close at 5pm,...

Kia ora   We are writing to inform you of a change for olanzapine depot injections.   Currently, to initiate a patient on treatment with olanzapine depot injection prescribers must submit an Exceptional Circumstances application using a NPPA form. This was implemented to manage the supply issue with olanzapine depot.   Key date: From 1 February 2026 , prescribers will instead be able to submit a Special Authority application to initiate treatment. Patients already on olanzapine depot inj will...

Please see advert below:

Discontinuation:   We are writing to remind you that NovoNordisk are rationalising their product range and discontinuing four insulins. Please begin transitioning your patients to suitable alternatives.   Key Dates: PenMix30 Penfill 3ml Supply of the PenMix30 ended October 2025. The remaining stock expires in April 2026. This will be delisted (no longer funded) 1 May 2026. Please see advice:  NZSSD Guidance: Discontinuation of Penmix30 and Penmix50 and Mixtard 30 , July 2024. Note this advice...